Bronchial asthma pharmacology

39

description

pharmacology

Transcript of Bronchial asthma pharmacology

Page 1: Bronchial asthma pharmacology
Page 2: Bronchial asthma pharmacology
Page 3: Bronchial asthma pharmacology

Objectives What is bronchial asthma?

Etiology

Pathophysiology of Asthma

Approaches to treatment

Phamacotherapy

Treatment plan

Drug delivery

Status Asthmaticus

Page 4: Bronchial asthma pharmacology

Bronchial Asthma

300 million people

Adult 10-12 %

Children 15%

Page 5: Bronchial asthma pharmacology

Bronchial Asthma

Definition: It is a syndrome

characterised by inflammation

and hyperresponsiveness of

tracheobronchial tree resulting

in reversible narrowing of air

tubes, mucosal oedema and

mucus plugging.

Page 6: Bronchial asthma pharmacology

Etiology

Page 7: Bronchial asthma pharmacology

Pathophysiology

Page 8: Bronchial asthma pharmacology

Pathophysiology

Page 9: Bronchial asthma pharmacology
Page 10: Bronchial asthma pharmacology

Signs & Symptoms Dyspnoea

Wheezing

Cough

Limitation of activity

Page 11: Bronchial asthma pharmacology

Approaches To TreatmentPrevention of Ag : Ab reaction

Neutralisation of IgE

Suppression of inflammation and hyperreactivity

Prevention of release of mediators

Antagonism of released mediators

Blockade of constrictor neurotransmittor

Mimicking dilator neurotransmittor

Directly acting bronchodilators

Page 12: Bronchial asthma pharmacology

Drugs used in Asthma

Bronchodilators

• β2 agonists

• Methylxanthines

• Anticholinergics

Anti-inflammatory

agents

• Corticosteroids

• Chromones

• Lukasts

• 5-LOX inhibitor

• Antihistaminics

• 5-HT antagonists

Miscellaneous

• Mucolytics

• Antibiotics

• Monoclonal antibodies

• Desensitization

12

Page 13: Bronchial asthma pharmacology

Bronchodilators

β2

agonistsSABA:

• Salbutamol

• Terbutaline

LABA:

• Salmeterol

• Formeterol

Methylxanthines

Theophylline

Anticholinergics

Tiotropiumbromide

Ipratropiumbromide

13

Page 14: Bronchial asthma pharmacology

β2 sympathomimeticsACTIONS:

Bronchodilatation

Inhibits mediator release

Increase mucus clearance

β2 receptor stimulation

Increased cAMP

Relaxation of bronchial muscle

Page 15: Bronchial asthma pharmacology

β2 Agonists

SABA

• Salbutamol, Terbutaline

• Maximum effect in 30 min

• Duration of action 4-6 hrs

• Used on ‘as needed’ basis

LABA

• Salmeterol, Formoterol

• Duration of action 12 hrs

• Used regularly

Page 16: Bronchial asthma pharmacology

β2 agonists

ADRs

Muscle tremors

Palpitation,restlessness

Ankle edema

Throat irritation

Page 17: Bronchial asthma pharmacology

MethylxanthinesTheophylline

Bronchodilatation

release of mediators

Narrow margin of safety

Ideal for night time symptoms

OTHER USES

COPD

Apnoea in premature infants

Mechanism of Action

adenylylcyclase

ATP

cAMP

5 AMP

Phosphodiesterase

Theophylline

Page 18: Bronchial asthma pharmacology

Adverse effectsGastric pain, vomiting

Tremors, palpitation

Hypotension

Convulsions

Insomnia

Page 19: Bronchial asthma pharmacology

Drug Interactions agents inducing metabolism

smoking

phenytoin

rifampicin

agents inhibiting metabolism erythromycin

OCPs

ciprofloxacin

Page 20: Bronchial asthma pharmacology

AnticholinergicsIpratropium bromide, Tiotropium bromideACTIONS:

Relaxes bronchial smooth muscle

may increase mucociliary clearance

act in larger airways

less effective than sympathomimetics

suitable for prophylactic use

combination is useful

very few side effects - safe

Page 21: Bronchial asthma pharmacology

Mechanism of Action

Page 22: Bronchial asthma pharmacology

Anti-inflammatory Agents

Corticosteroids

Inhalational:

• Beclomethasone

• Flunisolide

• Budesonide

Systemic:

• Hydrocortisone

• Prednisolone

• Methyl prednisolone

Chromones

Cromolyn sodium

( MDI )

Nedocromil

22

Page 23: Bronchial asthma pharmacology

Anti-inflammatory Agents (cont..)5-HT inhibitors & Antihistaminic

Ketotifen

(Oral )

Pizotifen

Lukasts ( Oral )

Zafirlukast

Montelukast

Pranlukast

Acolade

5-LOX inhibitors

Zileuton

(oral)

23

Page 24: Bronchial asthma pharmacology

CorticosteroidsPrednisolone, BeclomethasoneADVANTAGES

more complete and sustained relief

improve airflow

Influence airway remodeling

retard progression of disease

Page 25: Bronchial asthma pharmacology

Mechanism of Action

Page 26: Bronchial asthma pharmacology

Inhaled v/s Systemic corticosteroidsINHALED SYSTEMIC

Beclomethasone, BudesonideTargeted drug delivery

Systemic side effects are less

Used as a prophylactic drug

Cannot be withdrawn abruptly – bronchial hyperreactivity

Prednisolone, HydrocortisoneSystemic side effects are marked

Used in chronic severe asthma

Can be tapered rapidly

Page 27: Bronchial asthma pharmacology

Inhibits degranulation of mast cells

Restricted release of mediators

Inhibition of chemotaxis

CHROMONESSod cromoglycate, Nedocromil

Page 28: Bronchial asthma pharmacology

Chromones contd…

Long term treatment - cellular inflammatory response

Ineffective during an attack

USES

prophylaxis in asthma

allergic rhinitis

allergic conjunctivitis

Page 29: Bronchial asthma pharmacology

CHROMONES

Bronchospasm

Cough

Nasal congestion

Arthralgia

Rashes

ADRs

Page 30: Bronchial asthma pharmacology

Leukotriene AntagonistsMontelukast and Zafirlukast

Prophylaxis of mild to moderate asthma

Alternatives to inhaled Glucocorticoids

Acceptable in children

Effective in aspirin induced asthma

Safe drugs

Mode of action

AntagoniseLTs

Inhibit receptors

Page 31: Bronchial asthma pharmacology

Mechanism of Action

Page 32: Bronchial asthma pharmacology

Anti IgE AntibodyOmalizumab

Page 33: Bronchial asthma pharmacology
Page 34: Bronchial asthma pharmacology
Page 35: Bronchial asthma pharmacology

• Inhalational• Oral• Parenteral

Drug Delivery

Page 36: Bronchial asthma pharmacology
Page 37: Bronchial asthma pharmacology

Inhalational Drug Delivery SystemsMDI Dischalers Spacer

Rotahalers Nebulizer

37

Green[Salmeterol]

Orange[Fluticasone]

Blue[SABA]

Brown [budesonide]

Page 38: Bronchial asthma pharmacology

Status AsthmaticusAcute severe life threatening form of asthma.

TREATMENT:

Hydrocortisone 100mg iv stat

Nebulized Salbutamol 2.5-5mg +Ipratropium bromide 0.5 mg

High flow O2 inhalation

Salbutamol/ Terbutaline 0.4mg im/sc

Intubation and mechanical ventilation

Antibiotics

Saline + sod. bicarbonate

Page 39: Bronchial asthma pharmacology